i-Base home
Search Menu
  • Home
  • HTB
  • 2004
  • April
  • 03

3 April 2004

Contents

Editorial

  • Volume 5 number 3 April 2004

Treatment alerts

  • Risk factors for severe, life-threatening and fatal hepatotoxicity with nevirapine

Conference reports

  • 11th Conference on Retroviruses and Opportunistic Infections (CROI)
  • Drug levels can persist for more than two weeks after stopping efavirenz
  • Race affects absorption and clearance of efavirenz
  • Triple PI interactions: atazanavir increases saquinavir levels in ritonavir-boosted once-daily combination
  • Triple PI interactions: fosamprenavir and Kaletra interaction is difficult to overcome
  • Ribavirin (RBV) does not alter intracellular levels of AZT, 3TC or d4T
  • COLATE study shows no clinical benefit from continuing 3TC to maintain M184V mutation
  • Studies of new pipeline drugs
  • Little benefit seen for treatment during acute infection
  • Summary of resistance studies at Retrovirus
  • Update on peripheral neuropathy in HIV-infection
  • Smoking marijuana provides analgesic effect on HIV neuropathy
  • Two D:A:D updates: cardiovascular risk from HAART, and predictors of hypertension and changes in blood pressure
  • Low-dose rHGH maintains reductions in abdominal fat for 60 weeks
  • HTB RSS

Early access

  • AIDS quilts at the Tate: reflection and also anger 8 July 2025
  • US government has altered more than 100 scientific databases since 20 January 5 July 2025
  • All early access reports

Current issues

  • July 2025
  • June 2025
  • May 2025
  • Back issues

Special report

  • AIDS quilts at the Tate: reflection and also anger 8 July 2025

More from HTB

  • Conference reports
  • Conference shortcuts
  • Articles by subject
  • PDFs
  • Subscribe
  • HTB homepage

Home

  • i-Base homepage
  • Donate

This website sets no cookies from us or anyone else.

Information on this website is provided by treatment advocates and offered as a guide only. Decisions about your treatment should always be taken in consultation with your doctor.

HIV i-BASE
About us - Contact - Cookies and privacy - Copyright waiver - Terms of use - Home
Registered charity number: 1081905. Company number: 3962064.

Search i-Base

Site navigation

Quick links
HIV positive
Donate
Feedback
Advice and information
Q and A
Guides
HIV meds
Glossary
Research reports
HTB
HTB South
Pipeline report
Publications and resources
Publications
Other resources
Translations
Slide sets
Order and subscribe
Advocates' network
UK-CAB
Training manual
i-Base
About us
Contact
News and updates
Sitemap
Home
Find us on Facebook
i-Base on Facebook